Temporary Extension of Fentanyl-Related Substances Scheduling Act

#724 | S Congress #119

Last Action: Read twice and referred to the Committee on the Judiciary. (2/25/2025)

Bill Text Source: Congress.gov

Summary and Impacts
Original Text

Bill Summary

The "Temporary Extension of Fentanyl-Related Substances Scheduling Act" is a legislative proposal aimed at extending the temporary scheduling order for fentanyl-related substances by an additional six months. Specifically, it amends the existing law (Public Law 116-114) to change the expiration date of the temporary scheduling order from March 31, 2025, to September 30, 2025. This extension seeks to maintain regulatory control over fentanyl analogues, which are potent synthetic opioids that pose significant risks to public health, during the additional time needed for further study and evaluation of these substances.

Possible Impacts

Here are three examples of how the "Temporary Extension of Fentanyl-Related Substances Scheduling Act" could affect people:

1. **Access to Pain Management Medications**: By extending the temporary scheduling order for fentanyl-related substances, the legislation may impact patients who rely on these substances for pain management. While it could help prevent misuse and trafficking, it might also limit access for legitimate medical use, leading to challenges for healthcare providers in prescribing effective pain relief options.

2. **Law Enforcement and Public Safety**: The extension of the scheduling order gives law enforcement agencies the tools to combat the illegal distribution of fentanyl-related substances. This could lead to a potential decrease in overdose deaths and drug-related crimes, thereby improving public safety. However, it could also strain resources as law enforcement may need to increase efforts to address the illegal drug trade.

3. **Impact on Drug Policy and Addiction Treatment**: The legislation may influence ongoing discussions about drug policy and addiction treatment. By maintaining strict controls on fentanyl-related substances, it could hinder the development of new treatment options for opioid use disorder that incorporate these substances. Conversely, it could also promote greater awareness and funding for addiction treatment programs as the government continues to address the opioid crisis.

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 724 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  1st Session
                                 S. 724

     To extend the temporary scheduling order for fentanyl-related 
                        substances for 6 months.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           February 25, 2025

  Mr. Booker introduced the following bill; which was read twice and 
               referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL


 
     To extend the temporary scheduling order for fentanyl-related 
                        substances for 6 months.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Temporary Extension of Fentanyl-
Related Substances Scheduling Act''.

SEC. 2. EXTENSION OF TEMPORARY ORDER FOR FENTANYL-RELATED SUBSTANCES.

    Section 2 of the Temporary Reauthorization and Study of the 
Emergency Scheduling of Fentanyl Analogues Act (Public Law 116-114; 134 
Stat. 103) is amended by striking ``March 31, 2025'' and inserting 
``September 30, 2025''.
                                 <all>